LINC00511 and melanoma: Silence of LINC00511 increased miR-610 in melanoma cells, and inhibition of miR-610 attenuated LINC00511 deficiency-induced decrease of cell viability, migration, and invasion of melanoma, suggesting that LINC00511 might contribute to melanoma progression through downregulation of miR-610.